Want a Steroid-Sparing Claim on Your Label? Start Here
Chronic glucocorticoid exposure, even at low doses, is now seen by regulators and clinicians as an unacceptable safety burden. Sponsors that prioritize steroid-toxicity from the outset position ...
The Trials Driving the Next Wave of Steroid-Sparing Innovation
A wave of clinical trial results using the STOX® Suite of clinical outcome assessments (COAs) in a range of diseases will soon reach the shore, helping to deliver new therapeutic options for ...
Landmark Study Shows Steroids Must Be Tapered Early
Steroids must be tapered early to avoid long-term steroid-toxicities, according to a landmark 3-year observational study of severe asthma patients. The latest data, published in the Journal of ...
Variable, Real-world Treatment Trajectories for Newly Diagnosed Asthma Patients
Real-world treatment regimens for asthma patients vary dramatically, according to a recently published paper by Markus et al.[1] The multinational study set out to address the lack of knowledge ...
An introduction to… Sam
“You don’t feel so alone when you know you’re not the only one struggling with steroid side effects.” More than 50 million people are on long-term glucocorticoid treatment and more than 40% of the ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
